Northpond Ventures
Investor profile
Venture capital
Northpond Ventures has backed 7 European tech companies across 9 funding rounds between 2018 and 2026, joining rounds totalling €629M. Most active in Healthtech and Software. Data as of Nov 2026.
Deals
9
distinct rounds
Companies
7
backed
Active span
2018–2026
9 yrs
Total round €
€629M
sum of rounds joined
Deals by year
distinct rounds / yearNorthpond Ventures — deals by year — interactive chart.
Data table
| Northpond Ventures — deals by year | |
|---|---|
| 2018 | 1 |
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 5 |
| 2026 | 1 |
Top sectors
by dealsNorthpond Ventures — top sectors — interactive chart.
Data table
| Northpond Ventures — top sectors | |
|---|---|
| Healthtech | 9 |
| Software | 1 |
Stages
by dealsNorthpond Ventures — stages — interactive chart.
Data table
| Northpond Ventures — stages | |
|---|---|
| Series A | 3 |
| Series B | 3 |
| Series C | 2 |
| Other | 1 |
Countries
by dealsNorthpond Ventures — countries — interactive chart.
Data table
| Northpond Ventures — countries | |
|---|---|
| UK | 6 |
| Germany | 1 |
| Ireland | 1 |
| Switzerland | 1 |
Co-investment network
shared roundsCo-investment network — interactive chart.
Hover a node for shared-deal counts; click a co-investor to open its profile.
Best viewed on a larger screen.
Frequent co-investors
shared rounds- GV2
- Oxford Science Enterprises2
- Sanofi Ventures2
- Syncona Partners2
- 1kx1
- Amadeus Capital Partners1
- Backed VC1
- Bain Capital Life Sciences1
- Balaji Srinivasan1
- Boom Capital1
- Borealis Ventures1
- BoxGroup1
- Bristol Myers Squibb1
- British Business Bank1
- Chimera Partners1
- Chris Leiter1
- Compound VC1
- Delin Ventures1
- Fifty Years1
- Forbion1
- Founders Fund1
- Healthspan Capital1
- Inflection1
- Janus Henderson Investors1
- Jefferson Life Sciences1
Portfolio
top 30 by total round €| Company | Country | Rounds | Total € |
|---|---|---|---|
| OMass Therapeutics | UK | 2 | €362M |
| Ori Biotech | UK | 2 | €114M |
| Transition Bio | UK | 1 | €47M |
| Opna Bio | Switzerland | 1 | €37M |
| Current Health | UK | 1 | €36M |
| Teckro | Ireland | 1 | €22M |
| Molecule | Germany | 1 | €12M |
Biggest deals
top 10 by amount| Company | Stage | Amount | Date |
|---|---|---|---|
| OMass Therapeutics | Series B | €90M | 2022-04 |
| Ori Biotech | Series B | €88M | 2022-01 |
| Transition Bio | Series A | €47M | 2022-06 |
| Opna Bio | Series A | €37M | 2022-11 |
| Current Health | Series B | €36M | 2021-04 |
| Ori Biotech | Series A | €26M | 2020-10 |
| Teckro | Series C | €22M | 2019-01 |
| Molecule | Other | €12M | 2022-06 |